SolasCure selected for innovate UK global incubator programme in houston

FHS
June 3, 2024
10:41 am

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, today announced it has been selected for Innovate UK’s Global Incubator Programme in Houston, US.

Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance

Novartis is opening a new manufacturing facility in California and expanding an existing production site in its bid to dominate the booming radiopharmaceuticals field amid

September 4, 2024

ASCO preview: a promising solid tumor CAR-T, an AI patient navigator, and improving palliative care

Thousands of cancer researchers and clinicians are flocking to Chicago for the American Society of Clinical Oncology annual meeting that starts Friday. The ASCO meeting

May 27, 2024

Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes

Dive Brief: Insulet is looking to expand the label for its Omnipod 5 insulin pump for people with Type 2 diabetes. The company said Friday

June 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.